CHICAGO/BERLIN: The handful of drugmakers dominating the global coronavirus vaccine race are pushing the boundaries of vaccine technology. The next crop under development feature more conventional, proven designs. The world will need several different vaccines to fight the COVID-19 pandemic, given the sheer size of global need, variations in effects on different populations, and possible limits of effectiveness in the first crop. Many leading candidates now in final-stage testing are based on new, largely unproven technology platforms designed to produce vaccines at speed. They include messenger RNA (mRNA) technology used by Moderna Inc and Pfizer Inc with partner BioNTech SE , and inactiva
Read More Details
Finally We wish PressBee provided you with enough information of ( Next crop of COVID-19 vaccine developers take more traditional route )
Also on site :